Damora Therapeutics, Inc 10-Q for FY2026 Q2
Damora Therapeutics, Inc. (DMRA)
10-Q
2026-08-10
For: 2026-06-30
View Original
Added on
August 10, 2026
About this 10-Q
Damora Therapeutics, Inc filed this 10-Q on August 10, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $31.17M
- compared with a net loss of $3.44M a year earlier
- Diluted EPS
- -$0.39
- compared with -$2.60 a year earlier